Canatu receives further reactor order from FST, validating its CNT technology for pellicle manufacturingVantaa, Finland, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Canatu Plc (CANATU, Nasdaq First North Growth Market Finland) has received an order for further CNT100 SEMI reactor from Korean semiconductor company FINE SEMITECH CORPORATION (FST).
Canatu grants license for commercial production of CNT pellicle membranes using CNT100 SEMI reactorVANTAA, Finland, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Canatu has granted a commercial production license for the first CNT100 SEMI reactor to Korean semiconductor company FINE SEMITECH CORPORATION (hereinafter “FST”). The license authorizes FST as the licensee to mass-produce CNT pellicle membranes using the CNT100 SEMI reactor, which will be operated by FST. FST will pay Canatu a one-time license fee for the commercial production rights.
Canatu receives customer approval for its CNT100 SEMI reactor and post-processing equipment, enabling mass production of advanced EUV pelliclesVantaa, Finland, July 11, 2025 (GLOBE NEWSWIRE) -- Canatu Plc (CANATU, Nasdaq First North, Finland) has received Site Acceptance Test (SAT) approval for its first CNT100 SEMI reactor and for the related post-processing peripherals, shipped to a semiconductor customer in September 2024. The equipment successfully passed the extensive tests conducted on-site at the customer’s premises and met the stringent technical requirements and specifications defined in the acceptance criteria. This confirms the CNT100 SEMI reactor’s readiness for mass production of CNT pellicle membranes.
Canatu Drives Strong Momentum by Delivering Its First S-100 Reactor to Global Semiconductor CustomerVANTAA, FINLAND, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Canatu (CANATU, Nasdaq First North, Finland), a deep technology company creating advanced carbon nanotubes (Canatu CNTs), related products, and manufacturing equipment for the semiconductor, automotive, and medical diagnostics industries, announces a significant milestone with the delivery of its first S-100 reactor for a major global semiconductor customer. The Canatu S-100 reactor, customized to produce high-precision CNT membranes, is currently being installed at the customer’s site, with production set to begin shortly after installation.
Former Intel executive Thomas Lantzsch joins Canatu’s Board of DirectorsVANTAA, FINLAND, April 16, 2024 (GLOBE NEWSWIRE) -- Canatu, the global leader in developing advanced carbon nanotubes (Canatu CNTs) and manufacturing equipment for the semiconductor and automotive industries, today announced the appointment of former Intel executive Thomas Lantzsch to Canatu’s Board of Directors. With over 40 years of experience as an Executive Business Leader across Fortune 500 companies and early-stage startups, Lantzsch brings a wealth of semiconductor experience to Canatu.
